{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:42:00Z","timestamp":1783086120153,"version":"3.54.6"},"reference-count":47,"publisher":"Genomic Press","issue":"1","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,24]]},"abstract":"<jats:p><jats:bold>Body dysmorphic disorder (BDD) is a severe psychiatric condition characterized by preoccupation with perceived flaws in one's appearance, which the individual views as defective or ugly. Psilocybin, a serotonin 2A receptor agonist with psychedelic properties, has emerged as a potential therapeutic agent for depression and other psychiatric disorders. This study aimed to identify subacute neural changes predicting symptomatic response to psilocybin treatment in adults with BDD. Eight adults with moderate-to-severe nondelusional BDD were administered a single oral 25 mg dose of psilocybin, accompanied by psychological support, and underwent resting state functional magnetic resonance imaging assessments 1 day before and 1 day after the dosing. Both a region of interest (ROI)-to-ROI analysis and multivariate pattern analysis (MVPA) were used to identify changes in resting state functional connectivity (rsFC) at day 1 after dosing that predicted treatment response at week 1, measured by change in Yale-Brown Obsessive Compulsive Disorder Scale Modified for BDD (BDD-YBOCS) score. All participants completed the dosing and follow-up assessments over 12 weeks. BDD-YBOCS scores decreased at week 1 and week 12 after dosing (<jats:italic>p<\/jats:italic>&lt;0.001 for both). MVPA revealed a significant increase in rsFC within the Executive Control Network (ECN) at day 1. Increased rsFC within the ECN (dlPFC \u2013 Superior Parietal Lobule [FPL]), between the ECN and Default Mode Network (dlPFC \u2013 Precuneus), and between the ECN and the Salience Network (dlPFC \u2013 insula) were predictive of improvement in BDD symptoms at week 1. These findings are the first report of subacute brain effects of psilocybin in patients with BDD. Given the small sample size and uncontrolled design of the study, larger controlled studies are necessary to validate these observations.<\/jats:bold><\/jats:p>\n<jats:p><jats:bold>Clinical Trials Registration: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\">Clinicaltrials.gov<\/jats:ext-link> ID: NCT04656301<\/jats:bold><\/jats:p>","DOI":"10.61373\/pp024r.0028","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T21:16:31Z","timestamp":1731446191000},"page":"25-31","source":"Crossref","is-referenced-by-count":6,"title":["Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder"],"prefix":"10.61373","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2634-2901","authenticated-orcid":true,"given":"Xi","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA"},{"name":"Anxiety Disorders Clinic, New York State Psychiatric Institute, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1888-1063","authenticated-orcid":true,"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Anxiety Disorders Clinic, New York State Psychiatric Institute, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hellerstein","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie D.","family":"Feusner","sequence":"additional","affiliation":[{"name":"Division of Neurosciences and Clinical Translation, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Wheaton","sequence":"additional","affiliation":[{"name":"Anxiety Disorders Clinic, New York State Psychiatric Institute, New York, NY, USA"},{"name":"Barnard College, Columbia University, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria J.","family":"Gomez","sequence":"additional","affiliation":[{"name":"Anxiety Disorders Clinic, New York State Psychiatric Institute, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Schneier","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA"},{"name":"Anxiety Disorders Clinic, New York State Psychiatric Institute, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"40195","reference":[{"key":"R1","article-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5\u24c5\u02bc)","year":"2013","unstructured":"Association AP. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5\u24c5\u02bc). Washington, D.C: American Psychiatric Publishing; 2013."},{"issue":"4","key":"R2","series-title":"CNS Spectr","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1017\/s1092852900016436","article-title":"The prevalence of body dysmorphic disorder in the United States adult population","volume":"13","year":"2008","unstructured":"Koran LM, Abujaoude E, Large MD, Serpe RT. The prevalence of body dysmorphic disorder in the United States adult population. CNS Spectr. 2008;13(4):316\u201322. DOI: 10.1017\/s1092852900016436. PMID: 18408651"},{"issue":"6","key":"R3","series-title":"Psychol Med","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1017\/S0033291706007264","article-title":"The prevalence of body dysmorphic disorder: a population-based survey","volume":"36","year":"2006","unstructured":"Rief W, Buhlmann U, Wilhelm S, Borkenhagen A, Brahler E. The prevalence of body dysmorphic disorder: a population-based survey. Psychol Med. 2006;36(6):877\u201385. DOI: 10.1017\/S0033291706007264. PMID: 16515733"},{"issue":"4","key":"R4","series-title":"Psychosomatics","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1176\/appi.psy.46.4.317","article-title":"Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder","volume":"46","year":"2005","unstructured":"Phillips KA, Menard W, Fay C, Weisberg R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics. 2005;46(4):317\u201325. DOI: 10.1176\/appi.psy.46.4.317. PMID: 16000674; PMCID: PMC1351257"},{"issue":"5","key":"R5","series-title":"PLoS One","doi-asserted-by":"publisher","first-page":"e0213974","DOI":"10.1371\/journal.pone.0213974","article-title":"Differentiating weight-restored anorexia nervosa and body dysmorphic disorder using neuroimaging and psychometric markers","volume":"14","year":"2019","unstructured":"Vaughn DA, Kerr WT, Moody TD, Cheng GK, Morfini F, Zhang A,  Differentiating weight-restored anorexia nervosa and body dysmorphic disorder using neuroimaging and psychometric markers. PLoS One. 2019;14(5):e0213974. DOI: 10.1371\/journal.pone.0213974. PMID: 31059514; PMCID: PMC6502309"},{"issue":"10","key":"R6","series-title":"Eur Neuropsychopharmacol","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.euroneuro.2016.04.011","article-title":"Degree connectivity in body dysmorphic disorder and relationships with obsessive and compulsive symptoms","volume":"26","year":"2016","unstructured":"Beucke JC, Sepulcre J, Buhlmann U, Kathmann N, Moody T, Feusner JD. Degree connectivity in body dysmorphic disorder and relationships with obsessive and compulsive symptoms. Eur Neuropsychopharmacol. 2016;26(10):1657\u201366. DOI: 10.1016\/j.euroneuro.2016.04.011. PMCID: PMC5316290"},{"issue":"2","key":"R7","series-title":"Arch Gen Psychiatry","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/archgenpsychiatry.2009.190","article-title":"Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder","volume":"67","year":"2010","unstructured":"Feusner JD, Moody T, Hembacher E, Townsend J, McKinley M, Moller H,  Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder. Arch Gen Psychiatry. 2010;67(2):197\u2013205. DOI: 10.1001\/archgenpsychiatry.2009.190. PMID: 20124119; PMCID: PMC2853756"},{"issue":"2","key":"R8","series-title":"J Integr Neurosci","doi-asserted-by":"publisher","first-page":"45","DOI":"10.31083\/j.jin2102045","article-title":"What scans see when patients see defects: neuroimaging findings in body dysmorphic disorder","volume":"21","year":"2022","unstructured":"Machremi E, Bakirtzis C, Karakasi MV, Boziki MK, Siokas V, Aloizou AM,  What scans see when patients see defects: neuroimaging findings in body dysmorphic disorder. J Integr Neurosci. 2022;21(2):45. DOI: 10.31083\/j.jin2102045. PMID: 35364633"},{"issue":"1","key":"R9","series-title":"BMC Psychiatry","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12888-020-02489-0","article-title":"Treatment utilization and treatment barriers in individuals with body dysmorphic disorder","volume":"20","year":"2020","unstructured":"Schulte J, Schulz C, Wilhelm S, Buhlmann U. Treatment utilization and treatment barriers in individuals with body dysmorphic disorder. BMC Psychiatry. 2020;20(1):69. DOI: 10.1186\/s12888-020-02489-0. PMID: 32070300; PMCID: PMC7027080"},{"issue":"1","key":"R10","series-title":"Sci Rep","doi-asserted-by":"publisher","first-page":"13187","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms","volume":"7","year":"2017","unstructured":"Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB,  Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Sci Rep. 2017;7(1):13187. DOI: 10.1038\/s41598-017-13282-7. PMID: 29030624; PMCID: PMC5640601"},{"key":"R11","series-title":"J Affect Disord","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jad.2024.02.089","article-title":"Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity","volume":"353","year":"2024","unstructured":"Copa D, Erritzoe D, Giribaldi B, Nutt D, Carhart-Harris R, Tagliazucchi E. Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity. J Affect Disord. 2024;353:60\u20139. DOI: 10.1016\/j.jad.2024.02.089. PMID: 38423367"},{"key":"R12","series-title":"Front Psychiatry","doi-asserted-by":"publisher","first-page":"1178529","DOI":"10.3389\/fpsyt.2023.1178529","article-title":"Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial","volume":"14","year":"2023","unstructured":"Ching THW, Grazioplene R, Bohner C, Kichuk SA, DePalmer G, D'Amico E,  Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial. Front Psychiatry. 2023;14:1178529. DOI: 10.3389\/fpsyt.2023.1178529. PMID: 37181888; PMCID: PMC10166878"},{"issue":"1","key":"R13","series-title":"J Psychopharmacol","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/02698811221125354","article-title":"Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression","volume":"37","year":"2023","unstructured":"Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R. Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression. J Psychopharmacol. 2023;37(1):70\u20139. DOI: 10.1177\/02698811221125354. PMID: 36433778; PMCID: PMC9834320"},{"issue":"18","key":"R14","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","year":"2022","unstructured":"Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC,  Single-dose psilocybin for a treatment-resistant episode of major depression. N Engl J Med. 2022;387(18):1637\u201348. DOI: 10.1056\/NEJMoa2206443. PMID: 36322843"},{"issue":"5","key":"R15","series-title":"BJPsych Open","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1192\/bjo.2022.565","article-title":"Effects of psilocybin versus escitalopram on rumination and thought suppression in depression","volume":"8","year":"2022","unstructured":"Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ,  Effects of psilocybin versus escitalopram on rumination and thought suppression in depression. BJPsych Open. 2022;8(5):e163. DOI: 10.1192\/bjo.2022.565. PMID: 36065128; PMCID: PMC9534928"},{"issue":"7","key":"R16","series-title":"Soc Cogn Affect Neurosci","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/scan\/nsab130","article-title":"Maladaptive self-focused attention and default mode network connectivity: a transdiagnostic investigation across social anxiety and body dysmorphic disorders","volume":"17","year":"2022","unstructured":"Fang A, Baran B, Beatty CC, Mosley J, Feusner JD, Phan KL,  Maladaptive self-focused attention and default mode network connectivity: a transdiagnostic investigation across social anxiety and body dysmorphic disorders. Soc Cogn Affect Neurosci. 2022;17(7):645\u201354. DOI: 10.1093\/scan\/nsab130. PMID: 34875086;  PMCID: PMC9250304"},{"key":"R17","series-title":"Front Psychiatry","doi-asserted-by":"publisher","first-page":"1214803","DOI":"10.3389\/fpsyt.2023.1214803","article-title":"A qualitative exploration of the lived experiences of body dysmorphic disorder","volume":"14","year":"2023","unstructured":"Brennan SN, Rossell SL, Rehm I, Thomas N, Castle DJ. A qualitative exploration of the lived experiences of body dysmorphic disorder. Front Psychiatry. 2023;14:1214803. DOI: 10.3389\/fpsyt.2023.1214803. PMID: 37854447; PMCID: PMC10580279"},{"issue":"1","key":"R18","series-title":"J Psychopharmacol","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/02698811211026454","article-title":"Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals","volume":"36","year":"2022","unstructured":"McCulloch DE, Madsen MK, Stenbaek DS, Kristiansen S, Ozenne B, Jensen PS,  Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals. J Psychopharmacol. 2022;36(1):74\u201384. DOI: 10.1177\/02698811211026454. PMID: 34189985; PMCID: PMC8801642"},{"issue":"1","key":"R19","series-title":"Sci Rep","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1038\/s41598-020-59282-y","article-title":"Emotions and brain function are altered up to one month after a single high dose of psilocybin","volume":"10","year":"2020","unstructured":"Barrett FS, Doss MK, Sepeda ND, Pekar JJ, Griffiths RR. Emotions and brain function are altered up to one month after a single high dose of psilocybin. Sci Rep. 2020;10(1):2214. DOI: 10.1038\/s41598-020-59282-y. PMID: 32042038; PMCID: PMC7010702"},{"issue":"4","key":"R20","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","year":"2022","unstructured":"Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D,  Increased global integration in the brain after psilocybin therapy for depression. Nat Med. 2022;28(4):844\u201351. DOI: 10.1038\/s41591-022-01744-z. PMID: 35411074"},{"issue":"1","key":"R21","series-title":"Transl Psychiatry","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","year":"2021","unstructured":"Doss MK, Povazan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH,  Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Transl Psychiatry. 2021;11(1):574. DOI: 10.1038\/s41398-021-01706-y. PMID: 34750350; PMCID: PMC8575795"},{"key":"R22","series-title":"J Psychiatr Res","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jpsychires.2023.03.031","article-title":"Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder","volume":"161","year":"2023","unstructured":"Schneier FR, Feusner J, Wheaton MG, Gomez GJ, Cornejo G, Naraindas AM,  Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder. J Psychiatr Res. 2023;161:364\u201370. DOI: 10.1016\/j.jpsychires.2023.03.031. PMID: 37004409; PMCID: PMC10967229"},{"issue":"1","key":"R23","series-title":"Psychopharmacol Bull","first-page":"17","article-title":"A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale","volume":"33","year":"1997","unstructured":"Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, Goodman WK. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull. 1997;33(1):17\u201322. PMID: 9133747"},{"key":"R24","article-title":"Clinical Global Impressions ECDEU Assessment Manual for Psychopharmacology","year":"1976","unstructured":"Guy W. Clinical Global Impressions ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute for Mental Health; 1976."},{"issue":"1","key":"R25","series-title":"Am J Psychiatry","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1176\/ajp.155.1.102","article-title":"The brown assessment of beliefs scale: reliability and validity","volume":"155","year":"1998","unstructured":"Eisen JL, Phillips KA, Baer L, Beer DA, Atala KD, Rasmussen SA. The brown assessment of beliefs scale: reliability and validity. Am J Psychiatry. 1998;155(1):102\u20138. DOI: 10.1176\/ajp.155.1.102. PMID: 9433346"},{"issue":"1","key":"R26","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56\u201362. DOI: 10.1136\/jnnp.23.1.56. PMID: 14399272; PMCID: PMC495331"},{"issue":"7","key":"R27","series-title":"Lancet Psychiatry","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","year":"2016","unstructured":"Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M,  Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry. 2016;3(7):619\u201327. DOI: 10.1016\/S2215-0366(16)30065-7. PMID: 27210031"},{"issue":"3","key":"R28","series-title":"Brain Connect","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/brain.2012.0073","article-title":"Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks","volume":"2","year":"2012","unstructured":"Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012;2(3):125\u201341. DOI: 10.1089\/brain.2012.0073. PMID: 22642651"},{"key":"R29","series-title":"Neurobiol Stress","doi-asserted-by":"publisher","first-page":"100418","DOI":"10.1016\/j.ynstr.2021.100418","article-title":"Stronger functional network connectivity and social support buffer against negative affect during the COVID-19 outbreak and after the pandemic peak","volume":"15","year":"2021","unstructured":"Xiao M, Chen X, Yi H, Luo Y, Yan Q, Feng T,  Stronger functional network connectivity and social support buffer against negative affect during the COVID-19 outbreak and after the pandemic peak. Neurobiol Stress. 2021;15:100418. DOI: 10.1016\/j.ynstr.2021.100418. PMID: 34805450; PMCID: PMC8592855"},{"key":"R30","series-title":"Neuroimage Clin","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.nicl.2016.05.005","article-title":"Functional resting-state fMRI connectivity correlates with serum levels of the S100B protein in the acute phase of traumatic brain injury","volume":"12","year":"2016","unstructured":"Thompson WH, Thelin EP, Lilja A, Bellander BM, Fransson P. Functional resting-state fMRI connectivity correlates with serum levels of the S100B protein in the acute phase of traumatic brain injury. Neuroimage Clin. 2016;12:1004\u201312. DOI: 10.1016\/j.nicl.2016.05.005. PMID: 27995066; PMCID: PMC5153599"},{"issue":"2","key":"R31","series-title":"Dialogues Clin Neurosci","doi-asserted-by":"publisher","first-page":"133","DOI":"10.31887\/DCNS.2018.20.2\/smarek","article-title":"The frontoparietal network: function, electrophysiology, and importance of individual precision mapping","volume":"20","year":"2018","unstructured":"Marek S, Dosenbach NUF. The frontoparietal network: function, electrophysiology, and importance of individual precision mapping. Dialogues Clin Neurosci. 2018;20(2):133\u201340. DOI: 10.31887\/DCNS.2018.20.2\/smarek. PMID: 30250390; PMCID: PMC6136121"},{"issue":"10","key":"R32","series-title":"Eur J Neurosci","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1111\/ejn.15830","article-title":"Transcranial magnetic stimulation over posterior parietal cortex modulates alerting and executive control processes in attention","volume":"56","year":"2022","unstructured":"Middag-van Spanje M, Duecker F, Gallotto S, de Graaf TA, van Heugten C, Sack AT,  Transcranial magnetic stimulation over posterior parietal cortex modulates alerting and executive control processes in attention. Eur J Neurosci. 2022;56(10):5853\u201368. DOI: 10.1111\/ejn.15830. PMID: 36161393; PMCID: PMC9828423"},{"key":"R33","series-title":"Psychiatry Res","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.psychres.2017.11.062","article-title":"Set shifting and visuospatial organization deficits in body dysmorphic disorder","volume":"260","year":"2018","unstructured":"Greenberg JL, Weingarden H, Reuman L, Abrams D, Mothi SS, Wilhelm S. Set shifting and visuospatial organization deficits in body dysmorphic disorder. Psychiatry Res. 2018;260:182\u20136. DOI: 10.1016\/j.psychres.2017.11.062. PMID: 29202381"},{"key":"R34","series-title":"J Psychiatr Res","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jpsychires.2014.06.003","article-title":"Impairment in local and global processing and set-shifting in body dysmorphic disorder","volume":"57","year":"2014","unstructured":"Kerwin L, Hovav S, Hellemann G, Feusner JD. Impairment in local and global processing and set-shifting in body dysmorphic disorder. J Psychiatr Res. 2014;57:41\u201350. DOI: 10.1016\/j.jpsychires.2014.06.003. PMID: 24972487; PMCID: PMC4260461"},{"key":"R35","series-title":"Neurosci Biobehav Rev","doi-asserted-by":"publisher","first-page":"104689","DOI":"10.1016\/j.neubiorev.2022.104689","article-title":"Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses","volume":"138","year":"2022","unstructured":"McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE,  Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses. Neurosci Biobehav Rev. 2022;138:104689. DOI: 10.1016\/j.neubiorev.2022.104689. PMID: 35588933"},{"issue":"1","key":"R36","series-title":"Biol Psychiatry","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biopsych.2024.01.002","article-title":"Neural mechanisms of resting-state networks and the amygdala underlying the cognitive and emotional effects of psilocybin","volume":"96","year":"2024","unstructured":"Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A. Neural mechanisms of resting-state networks and the amygdala underlying the cognitive and emotional effects of psilocybin. Biol Psychiatry. 2024;96(1):57\u201366. DOI: 10.1016\/j.biopsych.2024.01.002. PMID: 38185235"},{"issue":"7","key":"R37","series-title":"Neuropsychopharmacology","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/s41386-023-01545-z","article-title":"Acute psilocybin enhances cognitive flexibility in rats","volume":"48","year":"2023","unstructured":"Torrado Pacheco A, Olson RJ, Garza G, Moghaddam B. Acute psilocybin enhances cognitive flexibility in rats. Neuropsychopharmacology. 2023;48(7):1011\u201320. DOI: 10.1038\/s41386-023-01545-z. PMID: 36807609; PMCID: PMC10209151"},{"issue":"44","key":"R38","series-title":"J Neurosci","doi-asserted-by":"publisher","first-page":"14652","DOI":"10.1523\/JNEUROSCI.3048-14.2014","article-title":"Dissociable roles of right inferior frontal cortex and anterior insula in inhibitory control: evidence from intrinsic and task-related functional parcellation, connectivity, and response profile analyses across multiple datasets","volume":"34","year":"2014","unstructured":"Cai W, Ryali S, Chen T, Li CS, Menon V. Dissociable roles of right inferior frontal cortex and anterior insula in inhibitory control: evidence from intrinsic and task-related functional parcellation, connectivity, and response profile analyses across multiple datasets. J Neurosci. 2014;34(44):14652\u201367. DOI: 10.1523\/JNEUROSCI.3048-14.2014. PMID: 25355218; PMCID: PMC4212065"},{"key":"R39","series-title":"J Psychiatr Res","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jpsychires.2022.01.007","article-title":"Brain functional correlates of emotional face processing in body dysmorphic disorder","volume":"147","year":"2022","unstructured":"Borgers T, Kurten M, Kappelhoff A, Enneking V, Mollmann A, Schulte J,  Brain functional correlates of emotional face processing in body dysmorphic disorder. J Psychiatr Res. 2022;147:103\u201310. DOI: 10.1016\/j.jpsychires.2022.01.007. PMID: 35030511"},{"issue":"16","key":"R40","series-title":"Psychol Med","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1017\/S0033291715001397","article-title":"Functional connectivity for face processing in individuals with body dysmorphic disorder and anorexia nervosa","volume":"45","year":"2015","unstructured":"Moody TD, Sasaki MA, Bohon C, Strober MA, Bookheimer SY, Sheen CL,  Functional connectivity for face processing in individuals with body dysmorphic disorder and anorexia nervosa. Psychol Med. 2015;45(16):3491\u2013503. DOI: 10.1017\/S0033291715001397. PMID: 26219399; PMCID: PMC4879882"},{"issue":"5-6","key":"R41","series-title":"Brain Struct Funct","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00429-010-0262-0","article-title":"Saliency, switching, attention and control: a network model of insula function","volume":"214","year":"2010","unstructured":"Menon V, Uddin LQ. Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct. 2010;214(5-6):655\u201367. DOI: 10.1007\/s00429-010-0262-0. PMID: 20512370; PMCID: PMC2899886"},{"issue":"3","key":"R42","series-title":"Brain Struct Funct","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00429-015-0994-y","article-title":"Dissociable attentional and inhibitory networks of dorsal and ventral areas of the right inferior frontal cortex: a combined task-specific and coordinate-based meta-analytic fMRI study","volume":"221","year":"2016","unstructured":"Sebastian A, Jung P, Neuhoff J, Wibral M, Fox PT, Lieb K,  Dissociable attentional and inhibitory networks of dorsal and ventral areas of the right inferior frontal cortex: a combined task-specific and coordinate-based meta-analytic fMRI study. Brain Struct Funct. 2016;221(3):1635\u201351. DOI: 10.1007\/s00429-015-0994-y. PMID: 25637472; PMCID: PMC4791198"},{"key":"R43","series-title":"Neurosci Biobehav Rev","doi-asserted-by":"publisher","first-page":"104736","DOI":"10.1016\/j.neubiorev.2022.104736","article-title":"Anterior insula as a gatekeeper of executive control","volume":"139","year":"2022","unstructured":"Molnar-Szakacs I, Uddin LQ. Anterior insula as a gatekeeper of executive control. Neurosci Biobehav Rev. 2022;139:104736. DOI: 10.1016\/j.neubiorev.2022.104736. PMID: 35700753"},{"key":"R44","series-title":"J Psychiatr Res","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpsychires.2016.12.011","article-title":"Intrinsic inter-network brain dysfunction correlates with symptom dimensions in late-life depression","volume":"87","year":"2017","unstructured":"Li W, Wang Y, Ward BD, Antuono PG, Li SJ, Goveas JS. Intrinsic inter-network brain dysfunction correlates with symptom dimensions in late-life depression. J Psychiatr Res. 2017;87:71\u201380. DOI: 10.1016\/j.jpsychires.2016.12.011. PMID: 28017917; PMCID: PMC5336398"},{"issue":"3","key":"R45","series-title":"Brain Imaging Behav","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s11682-020-00323-5","article-title":"Brain activation and connectivity in anorexia nervosa and body dysmorphic disorder when viewing bodies: relationships to clinical symptoms and perception of appearance","volume":"15","year":"2021","unstructured":"Moody TD, Morfini F, Cheng G, Sheen CL, Kerr WT, Strober M,  Brain activation and connectivity in anorexia nervosa and body dysmorphic disorder when viewing bodies: relationships to clinical symptoms and perception of appearance. Brain Imaging Behav. 2021;15(3):1235\u201352. DOI: 10.1007\/s11682-020-00323-5. PMID: 32875486; PMCID: PMC7921207"},{"issue":"12","key":"R46","series-title":"Trends Cogn Sci","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.tics.2012.10.008","article-title":"The role of default network deactivation in cognition and disease","volume":"16","year":"2012","unstructured":"Anticevic A, Cole MW, Murray JD, Corlett PR, Wang XJ, Krystal JH. The role of default network deactivation in cognition and disease. Trends Cogn Sci. 2012;16(12):584\u201392. DOI: 10.1016\/j.tics.2012.10.008. PMID: 23142417; PMCID: PMC3501603"},{"issue":"9","key":"R47","series-title":"Hum Brain Mapp","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/hbm.25411","article-title":"Reduced network integration in default mode and executive networks is associated with social and personal optimism biases","volume":"42","year":"2021","unstructured":"Moser DA, Dricu M, Kotikalapudi R, Doucet GE, Aue T. Reduced network integration in default mode and executive networks is associated with social and personal optimism biases. Hum Brain Mapp. 2021;42(9):2893\u2013906. DOI: 10.1002\/hbm.25411. PMID: 33755272; PMCID: PMC8127148"}],"container-title":["Psychedelics"],"original-title":[],"link":[{"URL":"https:\/\/genomicpress.kglmeridian.com\/view\/journals\/psychedelics\/1\/1\/article-p25.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/genomicpress.kglmeridian.com\/downloadpdf\/journals\/psychedelics\/1\/1\/article-p25.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/genomicpress.kglmeridian.com\/downloadpdf\/journals\/psychedelics\/1\/1\/article-p25.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T13:57:09Z","timestamp":1745503029000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomicpress.kglmeridian.com\/view\/journals\/psychedelics\/1\/1\/article-p25.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":47,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.61373\/pp024r.0028","relation":{},"ISSN":["2997-268X","2997-2671"],"issn-type":[{"value":"2997-268X","type":"print"},{"value":"2997-2671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]}}}